Metabolic Surgery

Metabolic surgery significantly lowered risk for major adverse liver outcomes vs. nonsurgical management among patients with obesity and compensated cirrhosis from metabolic dysfunction-associated steatohepatitis, according to study data.

In a single-center cohort of patients with heart failure and obesity, weight-loss surgery led to improved clinical outcomes including reduced BMI and HbA1c and less reliance on diuretics, researchers reported.

It is more appropriate to use BMI as the determinant for metabolic and bariatric surgery in treatment of type 2 diabetes.

During the past 20 years, Endocrine Today has reported on advancements in bariatric and metabolic surgery, including the evolution of the procedure and growth of high-quality clinical trial data documenting efficacy and safety.